SCHEMBL5090103

SCHEMBL5090103

C[C@H]1CC[C@H](C)OS(=O)(=O)O1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7158553 1.00 CA1 (0.31) CA1CA9
SCHEMBL8468962 0.81
SCHEMBL7517263 0.81
SCHEMBL5989973 0.78
SCHEMBL31554776 0.78
SCHEMBL16672994 0.75
SCHEMBL14497680 0.75
SCHEMBL4966447 0.75
SCHEMBL126250 0.71
SCHEMBL98605 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008055963-A1 NOVEL METHOD FOR PRODUCING ORGANIC PHOSPHORUS COMPOUNDS, PHOSPHORUS COMPOUNDS PRODUCED USING SAID METHOD, THE METAL COMPLEXES OF SAID COMPOUNDS, AND USE OF SAME Rheinisch-Westfälische Technische Hochschule Aachen (DE) 2008-05-15 WO disclosed
WO-2008055963-A1 NOVEL METHOD FOR PRODUCING ORGANIC PHOSPHORUS COMPOUNDS, PHOSPHORUS COMPOUNDS PRODUCED USING SAID METHOD, THE METAL COMPLEXES OF SAID COMPOUNDS, AND USE OF SAME Rheinisch-Westfälische Technische Hochschule Aachen (DE) 2008-05-15 WO disclosed
US-7307037-B2 Metallic catalysts for chemo-, regio- and stereoselective reactions, and corresponding precursors CHEMI S.P.A. (IT) 2007-12-11 US disclosed
US-7307037-B2 Metallic catalysts for chemo-, regio- and stereoselective reactions, and corresponding precursors CHEMI S.P.A. (IT) 2007-12-11 US disclosed
US-7291753-B2 Transfer hydrogenation processes and catalysts ABDUR-RASHID KAMALUDDIN 2007-11-06 US disclosed
US-20050107248-A1 Metallic catalysts for chemo-, regio-and stereoselective reactions, and corresponding precursors CHEMI S.P.A. (IT) 2005-05-19 US disclosed
EP-1490173-A2 METALORGANIC CATALYSTS FOR CHEMO-, REGIO- AND STEREOSELECTIVE REACTIONS, AND CORRESPONDING PRECURSORS CHEMI S.p.A. (IT) 2004-12-29 EP disclosed
WO-2003074169-A2 METALORGANIC CATALYSTS FOR CHEMO-, REGIO- AND STEREOSELECTIVE REACTIONS, AND CORRESPONDING PRECURSORS CHEMI S.P.A. (IT) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107248-A1 Metallic catalysts for chemo-, regio-and stereoselective reactions, and corresponding precursors PHOSPHO1, OSTC, MAS1 CA1 59/4885CA9 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.